Table 1—

Sequences of oligonucleotides used as forward and reverse primers for real-time RT-PCR

Gene productForward primerReverse primer
Amphiregulin5′-TTTCGCTGGCGCTCTCA-3′5′-TTCCAACCCAGCTGCATAATG-3′
CINC-15′-GGGTGTCCCCAAGTAATGGA-3′5′-CAGAAGCCAGCGTTCACCA-3′
EPCR5′-ACAGCCTGGTGCAGTTGATCT-3′5′-AGCAGCTAACAGTCAGAGGAAAGAC-3′
IL-65′-ATATGTTCTCAGGGAGATCTTGGAA-3′5′-TGCATCATCGCTGTTCATACAA-3′
FGFR-45′-GTTGGCACGCAGCTCCTT-3′5′-GCAGGACCTTGTCCAGAGCTT-3′
MCP-15′-TGGCAAGATGATCCCAATGA-3′5′-AGCTTCTTTGGGACACCTGCT-3′
PAI-15′-AGCTGGGCATGACTGACATCT-3′5′-GCTGCTCTTGGTCGGAAAGA-3′
TF5′-CCCAGAAAGCATCACCAAGTG-3′5′-TGCTCCACAATGATGAGTGTT-3′
tPA5′-TTCTTCTCTGACCGGCTGAAG-3′5′-TGTTAAACAGATGCTGTGAGGTACAG-3′
uPA5′-ACAGCCATCCAGGACCATACA-3′5′-CCAAACGGAGCATCACCAA-3′
uPAR5′-TGCTGGGAAACCGGAGTTAC-3′5′-GGAACCTTGGCACCAGGAA-3′
VEGFR25′-CCACCCCAGAAATGTACCAAAC-3′5′-AAAACGCGGGTCTCTGGTT-3′
β-Actin5′-TTCAACACCCCAGCCATGT-3′5′-AGTGGTACGACCAGAGGCATACA-3′
  • CINC: chemokine-induced neutrophilic chemoattractant; EPCR: endothelial protein C receptor; IL: interleukin; FGFR: fibroblast growth factor receptor; MCP: monocyte chemoattractant protein; PAI: plasminogen activator inhibitor; TF: tissue factor; tPA: tissue-type plasminogen activator; uPA: urokinase-type plasminogen activator; uPAR: uPA receptor; VEGFR2: vascular endothelial growth factor receptor 2.